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The Sindbis virus envelope contains two species of integral membrane glycoproteins, El and E2. These
proteins form heterodimers, and three dimeric units assemble to form spikes incorporated into the viral surface
which play an important role in the specific attachment ofSindbis virus to host cells. To map the neutralization
epitopes on the surface of the virus, we constructed a Agtll expression library with cDNA inserts 100 to 300
nucleotides long obtained from randomly primed synthesis on Sindbis virus genomic RNA. This library was
screened with five different neutralizing monoclonal antibodies (MAbs) specific for E2 (MAbs 50, 51, 49, 18,
and 23) and with one neutralizing MAb specific for El (MAb 33). When 106 Agtll plaques were screened with
each antibody, four positive clones that reacted with E2-specific MAb 23 were found. These four clones
contained overlapping inserts from glycoprotein E2; the domain from residues 173 to 220 of glycoprotein E2
was present in all inserts, and we concluded that this region contains the neutralization epitope recognized by
the antibody. No clones that reacted with the other antibodies examined were found, and we concluded that
these antibodies probably recognize conformational epitopes not present in the Agtll library. We suggest that
the E2 domain from residues 173 to 220 is a major antigenic determinant ofSindbis virus and that this domain
is important for virus attachment to cells.
Neutralizing antibodies bind to surface structures of a
virion and interfere with the uptake and uncoating of a virus
(13). In at least some cases, the antibody neutralizes by
binding to the structure on the virus that interacts with a
receptor on the cell surface, thus directly blocking the virus
from interacting with its receptor, and antiidiotypic antibod-
ies made against such antibodies may function as antirecep-
tor antibodies (3, 6, 28). Various strategies have been used to
map the neutralization epitopes ofviruses. One is analysis of
genetic variants that are resistant to a monoclonal antibody
(MAb) (4, 5, 8, 11, 15, 21, 24, 27, 29). A second approach is
to assay the interaction of the antibody with peptides; test
polypeptides can be produced synthetically, by fragmenta-
tion of the protein, or by expression as fusion proteins in a
convenient system (10).
Neutralization antibodies specific for both El and E2 of
Sindbis virus have been isolated and characterized (2, 17, 19,
20, 22, 23). We previously sequenced variants resistant to
one or more ofsix neutralizing MAbs specific for E2 and one
neutralizing MAb specific for El to identify amino acid
changes that led to escape fro;-ti neutralization (24). All six
E2-specific MAbs selected variants in a domain of E2
between residues 181 and 216, indicating that this region was
of considerable importance for the antigenicity of E2. We
have also shown (28) that anti-idiotypic antibodies to three of
these E2-specific neutralizing antibodies function as antire-
ceptor antibodies in chicken cells, suggesting that the neu-
tralization epitopes defined by these antibodies form part of
the virus antireceptor that attaches to the host cell receptor
to initiate virus infection.
Mapping of amino acid changes that lead to loss of
antibody binding has often correctly identified residues that
form part of an epitope (reviewed in reference 9). Thus, it
seemed likely that the E2 domain defined by the amino acid
changes leading to escape from neutralization, which also
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lead to loss of the ability to bind the antibody, interacted
directly with the neutralizing MAbs and, by extension, that
this domain also forms part of the virus antireceptor. How-
ever, MAb-resistant variants in which single amino acid
substitutions away from the actual antibody-binding site
itself led to escape from neutralization have been described
(5, 14). In such cases, changes in conformation of the
antibody-binding domain were induced by substitutions out-
side the epitope. Thus, it is important to define, if possible,
the antibody-binding domain by using a direct binding
method. We reasoned that the bacterial expression vector
Agtll, in which foreign epitopes are expressed as fusion
proteins with ,B-galactosidase, might be suitable for this
purpose, provided that an epitope is contiguous. Recombi-
nant Agtll cDNA libraries can be screened with antibodies
to identify specific recombinant clones containing inserts
leading to reactivity with the antibody (30).
Construction and screening of the bacteriophage library.
Sindbis virus strain AR339, from A. Schmaljohn (24), was
grown in monolayers ofprimary chicken embryo fibroblasts
(16). Virus was purified, as previously described (1), and
disrupted with 0.5% sodium dodecyl sulfate, and 49S ge-
nomic RNA was extracted with phenol-chloroform (7). After
two ethanol precipitations, the RNA was suspended in
distilled H20 and stored at -70°C until use as a template for
cDNA synthesis.
A Agtll library containing short inserts of Sindbis virus
cDNA was constructed by a modification ofthe procedure of
Young and Davis (30). cDNA synthesis was randomly
primed with sonicated salmon testis DNA; [32P]dCTP was
included during cDNA synthesis to monitor the product.
After treatment with the Klenow fragment ofDNA polymer-
ase I, methylation with EcoRI methyltransferase, and addi-
tion ofEcoRI linkers (Collaborative Research), the modified
cDNA was digested with an excess of EcoRI restriction
enzyme. The digested cDNA was then fractionated on a
Sephadex CL-6B column (Pharmacia), and Sindbis virus
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FIG. 1. Reactivities of phage clones X23a and X23b with MAb 23. Immunoreactive phage plaques were picked and rescreened until a
uniformly reactive population was obtained. Illustrated are the final populations for two reactive clones and a nonreactive clone selected for
other reasons. These phage stocks were plaqued on E. coli Y1090 in the presence ofthe inducer, and plaques were transferred to nitrocellulose
filters as described in the text. The filter was incubated with MAb 23 and then with 125I-conjugated protein G and autoradiographed.
Comparison of the autoradiogram with the plaque population found on the petri plates from which the filters were obtained showed that all
ofthe phage plaques in X23a and X23b reacted with the antibody. A Xgtll population expressing E2 residues 129 to 192 did not react, as shown
at the right. aa, amino acids.
cDNA fragments 100 to 300 bp long were pooled and ligated
to dephosphorylated Xgtll arms (Promega). After in vitro
packaging into phage heads (Stratagene), the percentage of
phage containing Sindbis virus cDNA inserts was found to
be 90% by plating phage on Escherichia coli Y1090 in the
presence of 5-bromo-4-chloro-3-indolyl-,B-D-galactoside.
Plaques were screened for reactivity with the various MAbs.
Phage plaques were grown for 6 h at 42°C, nitrocellulose
disks (Schleicher & Schuell) soaked in 10 mM isopropyl-,3-
D-thiogalactopyranoside were then placed on the top of the
agar layer, and the plates were transferred to 37°C for 15 h.
The filters then were lifted and washed successively in 10
mM Tris-Cl (pH 7.5) and 150 mM NaCl containing 5% nonfat
milk. The filters were incubated overnight at 4°C with a MAb
(10 ,ug/ml in phosphate-buffered saline containing 5% nonfat
milk) and washed, 1251-conjugated protein G (0.5 ,Ci/ml in
5% nonfat milk) was added, and the filters were incubated
for at least 2 h at room temperature. After washing and
drying, the filters were exposed overnight at -80°C to
Kodak X-Omat film. Immunoreactive phage were picked
and rescreened until a uniformly reactive population was
obtained.
Mapping ofthe location ofE2 sequences reactive with MAb
23. The Agtll library containing randomly generated 100- to
300-bp Sindbis virus cDNA inserts in the lacZ gene was
tested for reactivity with six MAbs by using 1251I-labeled
protein G (Amersham) to detect the presence of the MAbs
(all were immunoglobulins G) bound to immunoreactive
phage clones on nitrocellulose filters. Four positive phage
clones, designated X23a, X23b, X23c, and X23d, were identi-
fied when MAb 23 was used to screen 106 plaques. The
reactivities of X23a and X23b with the antibody are shown in
Fig. 1. Results obtained with a negative Xgtll clone that
expresses a different region of E2 are also shown.
DNA was prepared from each of these four reactive
phages (30). The inserts were removed with EcoRI, sub-
cloned into vector M13mpl8, and sequenced by the dideoxy-
chain termination procedure (18). The four inserts contained
overlapping sequences from the central region of glycopro-
tein E2 (Fig. 2). The insert in X23a comprised E2 residues
155 to 258, that in X23b comprised residues 173 to 251, that
in X23c comprised residues 145 to 223, and that in X23d
comprised residues 169 to 220. Thus, the domain from
residues 173 to 220 is present in all four inserts and the
neutralizing epitope recognized by MAb 23 must lie within
this region.
During these experiments, additional Xgtll clones which
failed to react with MAb 23 were sequenced. Some ofthese
were found to express regions of E2. Noteworthy among
these were clones expressing E2 residues 129 to 192 (Fig. 1),
135 to 187, 141 to 203, 147 to 183, and 153 to 191. Thus, the
presence of residues between 204 and 220 are required (but
are not necessarily sufficient) for reactivity with MAb 23.
Results obtained with other MAbs. We also attempted to
identify fusion proteins immunoreactive with four other
E2-specific neutralizing MAbs, namely, MAbs 18, 50, 51,
and 49, as well as fusion proteins immunoreactive with MAb
33, which is specific for glycoprotein El. In each case, 106
plaques were screened. No positive plaques could be iden-
tified with any of these antibodies. We conclude that these
antibodies probably react with conformational epitopes not
present in the Xgtll library, because these epitopes either
are discontinuous or consist of conformations not assumed
by the fusion proteins.
An antibody-binding domain in E2. Various approaches
have been used to map the epitopes on proteins that react
with MAbs. Only determination of the three-dimensional
structure of the antigen-antibody complex can fully map the
interactive residues; of the five such structures determined,
the epitopes comprise 15 to 22 amino acids and are discon-
tinuous, formed from different parts ofthe polypeptide chain
(reviewed in reference 9). Furthermore, it is to be expected
that even if an epitope is contiguous, its conformation in the
native protein is important for its reactivity and short syn-
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FIG. 2. Schematic representation of an antigenically important domain of Sindbis virus glycoprotein E2. The genome region encoding
glycoprotein E2 is represented. The relative locations ofthe inserts in four Xgtll clones reactive with MAb 23 are mapped. The overlap region
in these four clones between residues 173 and 220 of E2 is expanded below, with a number of key features indicated. Residues altered in
variants resistant to MAbs are boxed (24), and a carbohydrate attachment site (CHO) is indicated. aa, amino acids.
thetic peptides might not react with the antibody. Previous
attempts to map the binding site for MAb 23 and other
anti-Sindbis virus MAbs by using synthetic peptides repre-
senting residues 175 to 194 and 206 to 220 ofSindbis virus E2
were not successful (18a). We have explored the use of the
Xgtll system as a way to identify regions of a virus protein
that react with neutralizing antibodies. If an epitope is
substantially contained within a contiguous region of the
polypeptide chain, and the polypeptide domain containing
the epitope is capable offolding into a reactive conformation
as part ofthe fusion protein, some fusion proteins expressed
in phage plaques might react with the MAb. We found that
one neutralizing MAb tested, MAb 23, reacted with fusion
proteins in Agtll plaques.
From the sequence of the inserts in the four clones
immunoreactive with MAb 23, it is clear that this antibody
can react with a single contiguous region of Sindbis virus
glycoprotein E2 and that the neutralization epitope must be
contained substantially, if not completely, within the 48
residues between amino acids 173 and 220. This result is
consistent with the results from mapping ofantibody escape
variants resistant to MAb 23 (Fig. 2). Sequencing of three
independent variants resistant to MAb 23 and two indepen-
dent revertants selected to be sensitive again to MAb 23, as
well as of other variants, has shown that residue 216 is
important for reactivity with MAb 23 (24). Viruses with
Lys-216 were fully sensitive to MAb 23, viruses with Val-216
or Ile-216 demonstrated reduced sensitivity to MAb 23, and
viruses with Glu-216 were resistant to MAb 23. From the
results obtained here, it appears likely, therefore, that resi-
due 216 interacts directly with MAb 23, forming part of the
epitope.
Although the remaining antibodies tested failed to react
with the Xgtll library, it seems likely that E2-specific MAbs
50, 51, 49, and 18 also bind to epitopes at least partially
encompassed within this same domain. Variants selected to
be resistant to these MAbs were all found to have amino acid
changes responsible for the escape from neutralization
within the domain from residues 181 to 216 (Fig. 2) (24).
Furthermore, MAb 23 and these other MAbs all react with
closely spaced or overlapping epitopes as defined by com-
petition assays or by the pattern of cross-reactivity of
different variants resistant to the various antibodies (4, 20,
24). Interestingly, residue 216 appears to form a component
not only of the epitope for MAb 23 but also of the epitopes
of MAbs 51, 18, and 8 (Fig. 2). The epitope for MAb 23
appears to be contiguous and located entirely within this
region. Those for the other MAbs tested, including 51 and
18, are either discontinuous, composed in part of residues
within this region and in part ofresidues in other regions, or
continuous, in which case the MAbs must react with con-
formations not present in the fusion library. The latter
explanation seems likely for at least MAbs 49 and 50,
because these MAbs react with sodium-dodecyl sulfate-
denatured and reduced E2 in a Western blot (immunoblot),
as is also the case for MAb 23 (18a).
The results are consistent with the hypothesis that the E2
domain between 173 and 220 forms a major antibody-binding
region important for neutralization of virus infectivity. This
domain is illustrated in Fig. 2, with the locations ofantibody
escape variants shown and the region selected by MAb 23
indicated. This domain is hydrophilic, containing 25%
charged residues, and has aglycosylation site at Asn-196 and
thus is almost certainly exposed on the surface of the
glycoprotein spike (25).
We have previously found that an anti-idiotypic antibody
to MAb 23, as well as anti-idiotypic antibodies to MAbs 49
and 50, functions as an antireceptor antibody in chicken cells
(28). This suggests that the E2 domain defined by the fusion
protein reactive with MAb 23 and by the antibody escape
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variants forms part ofthe antireceptor on the virus spike that
binds to the cellular receptor. This hypothesis is supported
by the observation that two strains of Sindbis virus that
differ only in having Gly or Arg at residue 172 of E2 differ in
both their ability to bind to neuroblastoma cells in culture
(26) and in their neurovirulence for mice (12).
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